相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modulation of Drug Resistance in Ovarian Cancer Cells by Inhibition of Protein Kinase C-alpha (PKC-α) with Small Interference RNA (siRNA) Agents
Li-Jun Zhao et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Characterization of cancer stem-like cells derived from a side population of a human gallbladder carcinoma cell line, SGC-996
Xin-xing Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Highly sensitive profiling of CD44+/CD24- breast cancer stem cells by combining global mRNA amplification and next generation sequencing: Evidence for a hyperactive PI3K pathway
Olaf Hardt et al.
CANCER LETTERS (2012)
The EMT signaling pathways in endometrial carcinoma
Eva Colas et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
The Cancer Stem-Cell Hypothesis Its Emerging Role in Lung Cancer Biology and Its Relevance for Future Therapy
John D. O'Flaherty et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-κB signaling pathway in a human breast cancer cell line
X. Lin et al.
NEOPLASMA (2012)
Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern
Ozlem Darcansoy Iseri et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
Eleonor Olsson et al.
BMC CANCER (2011)
Secondary mutations of BRCA1/2 and drug resistance
Kiranjit K. Dhillon et al.
CANCER SCIENCE (2011)
Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
M. Saxena et al.
CELL DEATH & DISEASE (2011)
Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy
Ahmad R. Safa et al.
Cancers (2011)
Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
Anna Maria Calcagno et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Cancer Stem Cells: A Novel Paradigm for Cancer Prevention and Treatment
D. Subramaniam et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and β-catenin signaling
Yong-Yu Liu et al.
MOLECULAR CANCER (2010)
Targeting NRF2 signaling for cancer chemoprevention
Mi-Kyoung Kwak et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Downregulation of GST pi expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis
Sung-Tsai Yu et al.
ANTI-CANCER DRUGS (2009)
Redox Regulation of Multidrug Resistance in Cancer Chemotherapy: Molecular Mechanisms and Therapeutic Opportunities
Macus Tien Kuo
ANTIOXIDANTS & REDOX SIGNALING (2009)
Altered Expression of Proliferation-Inducing and Proliferation-Inhibiting Genes Might Contribute to Acquired Doxorubicin Resistance in Breast Cancer Cells
Ekram M. Saleh et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2009)
Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway
Gi-seong Shim et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer
Johanne Weberpals et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates β-Catenin Signaling and NFκB-specific Transcription Activity Leading to MDR1 and Bcl-xL Gene Expression and Chemoresistance in Breast Tumor Cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Transport proteins of the ABC family and multidrug resistance of tumor cells
A. A. Stavrovskaya et al.
BIOCHEMISTRY-MOSCOW (2008)
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Anne-Pierre Morel et al.
PLOS ONE (2008)
Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells
Sung-Tsai Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Role of the MRP1/ABCC1 multidrug transporter protein in cancer
Marcia Munoz et al.
IUBMB LIFE (2007)
Stem cell biology and the cellular pathways of carcinogenesis
T Gudjonsson et al.
APMIS (2005)
Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway
C Shinoda et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Self-renewal and solid tumor stem cells
M Al-Hajj et al.
ONCOGENE (2004)
The role of p53 in chemosensitivity and radiosensitivity
WS El-Deiry
ONCOGENE (2003)
Transcriptional regulation of ABC drug transporters
KW Scotto
ONCOGENE (2003)
Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells
RB Walter et al.
BLOOD (2003)
Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications
M Nugoli et al.
BMC CANCER (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inorganic arsenic
M Schuliga et al.
TOXICOLOGICAL SCIENCES (2002)
Heme oxygenase/carbon monoxide signaling pathways: Regulation and functional significance
SW Ryter et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1
J Sampath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus
T Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Evidence for functionally significant polymorphism of human glutamate cysteine ligase catalytic subunit: Association with glutathione levels and drug resistance in the national cancer institute tumor cell line panel
AC Walsh et al.
TOXICOLOGICAL SCIENCES (2001)
Mechanism of resistance to oxidative stress in doxorubicin resistant cells
S Furusawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2001)
Modulation of MDR/MRP by wild-type and mutant p53
O Bähr et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
分享论文
